Establishing Long-Term Safety & Immunization Protocols After B-Cell Depletion Therapy

  • Understanding the data needed to establish evidence-based guidelines for revaccination timing and efficacy following deep B-cell depletion
  • Establishing a framework for determining the appropriate risk threshold for autoimmune patients to undergo deep B-cell depletion
  • Defining long-term surveillance markers to monitor the safety of B-cell depletion therapies using longitudinal immune monitoring data